Literature DB >> 18091377

B7-h4 expression in a range of breast pathology: correlation with tumor T-cell infiltration.

Kimberly C Mugler1, Meenakshi Singh, Barbara Tringler, Kathleen C Torkko, Wenhui Liu, Jackie Papkoff, Kenneth R Shroyer.   

Abstract

B7-H4, a member of the B7 family, is involved in the regulation of antigen-specific immune responses. Its expression in a range of breast pathology and correlation to the number of CD3 and CD8 tumor infiltrating T-lymphocytes in invasive carcinomas were explored. The proportion of B7-H4 positive cells, staining pattern, and intensity were evaluated within diagnostic groups (normal and benign lesional, potentially premalignant and in situ carcinoma, and invasive carcinoma) on archival tissue blocks by immunohistochemistry. The proportion and intensity of B7-H4 expression was progressively increased across the major diagnostic groups. There was a significant association between a high proportion of B7-H4 positive cells in invasive ductal carcinomas and decreased number of tumor infiltrating lymphocytes (P=0.002). The cellular distribution of B7-H4 appears altered in the spectrum of normal to malignant breast. Its overexpression may help cancers avoid immune detection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18091377     DOI: 10.1097/01.pai.0000213159.79557.71

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  22 in total

Review 1.  B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look.

Authors:  Jenessa B Smith; Caitlin Stashwick; Daniel J Powell
Journal:  Gynecol Oncol       Date:  2014-03-20       Impact factor: 5.482

2.  Host b7x promotes pulmonary metastasis of breast cancer.

Authors:  Yael M Abadi; Hyungjun Jeon; Kim C Ohaegbulam; Lisa Scandiuzzi; Kaya Ghosh; Kimberly A Hofmeyer; Jun Sik Lee; Anjana Ray; Claudia Gravekamp; Xingxing Zang
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

Review 3.  Potential targeting of B7-H4 for the treatment of cancer.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

4.  Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis.

Authors:  Ninu Maskey; Kai Li; Min Hu; Zhigao Xu; Chunwei Peng; Fang Yu; Hong Cao; Jiamei Chen; Yan Li; Guifang Yang
Journal:  Tumour Biol       Date:  2014-09-27

Review 5.  Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.

Authors:  Leisha A Emens
Journal:  Expert Rev Anticancer Ther       Date:  2012-12       Impact factor: 4.512

6.  B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancer.

Authors:  Hong Xu; Xiaoling Chen; Min Tao; Kai Chen; Chen Chen; Gang Xu; Wei Li; Suxu Yuan; Yixiang Mao
Journal:  Oncol Lett       Date:  2016-01-19       Impact factor: 2.967

7.  T-cell infiltration and expressions of T lymphocyte co-inhibitory B7-H1 and B7-H4 molecules among colorectal cancer patients in northeast China's Heilongjiang province.

Authors:  Ming Liang; Jingyuan Li; Dandan Wang; Shuchen Li; Yi Sun; Tiewei Sun; Jing Zhang; Xiaoning Chen; Qiang Li; Shibo Sun
Journal:  Tumour Biol       Date:  2013-07-20

Review 8.  B7-H4's role "beyond the tumor".

Authors:  Ning Yu; Xiaomei Li; Songguo Zheng; Xiangpei Li
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 9.  Fine tuning the immune response through B7-H3 and B7-H4.

Authors:  Kyung H Yi; Lieping Chen
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

10.  B7-H4 gene polymorphisms are associated with sporadic breast cancer in a Chinese Han population.

Authors:  Jie Zhang; Mingyan Zhang; Wei Jiang; Lihong Wang; Zhenkun Fu; Dalin Li; Da Pang; Dianjun Li
Journal:  BMC Cancer       Date:  2009-11-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.